SPRY4 and central nervous system cancer: Furthermore, overall survival of adult glioma patients with high SPRY4 levels is strongly reduced (Figure 4A), whereas in pediatric glioma patients, high expression of SPRY4 is associated with a non-significantly better prognosis (Figure 4B).